Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada 
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up 
Shein Shares Drop 5% After Weak Hong Kong IPO Debut 
Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses 
South Korea Unveils Record $597 Billion 2027 Budget to Boost AI and Chips 
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations 
Trump Says ExxonMobil Among Oil Majors Planning Venezuela Return 
Shein Shares Slide 9% in Hong Kong IPO Debut 
Trump Secures Drug Pricing Deals With Nine Pharma Companies 
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall 
Amazon Shares Fall as FTC Plans Ad Pricing Lawsuit 
OpenAI Nears Astra AI Model Launch With Safety Focus 
ByteDance Secures $29.6 Billion Loan to Boost AI Investment 
OpenAI Rejects Apple Trade Secret Theft Claims 
MediaTek Shares Jump 10% on Nvidia’s $3.5 Billion Investment 
Add as a preferred source on Google
NAPANEE, Ontario, March 16, 2018 -- ABcann Global Corporation (TSXV:ABCN) (Frankfurt:23Q) (OTC:ABCCF) ("ABcann" or the "Company") announced that Ken Clement, ABcann's founder and director, has resigned from the Board of Directors.
Paul Lucas, ABcann's Chair, commented, "On behalf of the Board, we thank Ken for his vision in starting the company and growing it from a start-up organization into a well-funded publicly-traded licensed producer with a bright future. We wish Ken well in his future endeavours."
About ABcann:
ABcann holds production and sales licenses from Health Canada. Its flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centred on its specially designed, environmentally-controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products.
The Company is expanding its cultivation capacity and pursuing partnerships and product development opportunities domestically, as well as in select international markets, such as Germany, Australia and Israel.
ON BEHALF OF THE BOARD OF DIRECTORS
"Barry Fishman"
Barry Fishman
CEO and Director
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact: Barry Fishman (CEO and Director) [email protected] Michael Bumby (CFO) [email protected]
